TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.1% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Organon & Co (OGN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 92.5% of the shares are freely tradable; institutional investors hold 77.9%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 77.9%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 0.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 92.5%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 7.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 263Mio.

Largest Shareholders

Institutions

Institutions OGN
Name Stake (%) Shares Change (%) Date
BlackRock Inc 12.08 31,717,028 +2.4 03/31/2026
Vanguard Portfolio Management, LLC 8.32 21,846,036 +0.0 03/31/2026
Pentwater Capital Management LP 6.89 18,100,000 +0.0 06/30/2026
Vanguard Capital Management, LLC 4.47 11,737,018 +0.0 03/31/2026
State Street Corp 3.79 9,956,774 +3.7 03/31/2026
Kahn Brothers & CO Inc /DE/ 2.11 5,536,993 +52.6 03/31/2026
Geode Capital Management, LLC 1.81 4,759,337 +3.5 03/31/2026

Funds

Funds OGN
Name Stake (%) Shares Change (%) Date
iShares Core S&P Small-Cap ETF 6.09 15,996,548 -0.1 08/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.18 8,361,147 +0.3 07/31/2026
Vanguard Small Cap Index 2.30 6,038,534 +0.2 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings OGN
Person Role Shares Value As of Type
Arjona Ferreira Juan Camilo Head of R&D & CMO 37,432 512,825 $ Aug 11, 2026 direct
Drinane Juliana Papa Head of Mfg & Supply 18,475 253,103 $ Aug 5, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Aug 11, 2026 Arjona Ferreira Juan Camilo Head of R&D & CMO Other 4,134 13.62 56,305
Aug 11, 2026 Arjona Ferreira Juan Camilo Head of R&D & CMO Other 11,519 0.00
Aug 5, 2026 Drinane Juliana Papa Head of Mfg & Supply Sell 14,761 13.57 200,307

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?